Navigating The Patient Experience When Pivoting To A Virtual Model Mid-Study
Source: Veristat, Inc.
Completing a natural history study for ultra-rare diseases can be critical to understanding the disease and its progression. The data from the natural history can be essential to informing the design and outcome selection of an interventional study. We explore the challenges of designing and running an extraordinary complex natural history study - with both retrospective and prospective data – which then had to pivot to virtual patient visits mid-way through the data collection process.
Our experts will share their experience, successes, and lessons learned on:
- The need for and challenges of a Natural History study of Canavan Disease
- Case Study: Strategies for addressing challenges of a unique study design
- Pivoting to a virtual & in-person hybrid model during COVID-19
VIEW THE WEBINAR!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Veristat, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more